William Hait - 03 Jan 2022 Form 3/A Insider Report for JOHNSON & JOHNSON (JNJ)

Role: Title: EVP, Chief External Innovation and Medical Officer
Signature: /s/ Raavi Deol, as attorney-in-fact for William Hait
Issuer symbol: JNJ
Transactions as of: 03 Jan 2022
Net transactions value: $0
Form type: 3/A
Filing time: 12 Feb 2024, 16:19:15 UTC
Date Of Original Report: 13 Jan 2022
Next filing: 18 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	JNJ	Common Stock						15,996	03 Jan 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This Form 3/A is being filed to correct the number of shares of common stock reported in Table I of the original Form 3 filed on January 13, 2022, as amended by the Form 3/A filed on February 18, 2022 ("Amended Form 3"), which Amended Form 3 inadvertently reported 71,609 shares beneficially owned by the reporting person instead of the 15,996 shares reported herein. This Form 3/A is deemed to update the number of securities reported as beneficially owned in any Forms 4 subsequently filed by the reporting person through the date hereof.

Content

This Form 3/A is being filed to correct the number of shares of common stock reported in Table I of the original Form 3 filed on January 13, 2022, as amended by the Form 3/A filed on February 18, 2022 ("Amended Form 3"), which Amended Form 3 inadvertently reported 71,609 shares beneficially owned by the reporting person instead of the 15,996 shares reported herein. This Form 3/A is deemed to update the number of securities reported as beneficially owned in any Forms 4 subsequently filed by the reporting person through the date hereof.

Remarks:

Title: EVP, Chief External Innovation and Medical Officer